Overview

This trial is active, not recruiting.

Condition acute pain
Sponsor Cure Cancer Worldwide, LLC
Start date May 2015
End date August 2020
Trial size 300 participants
Trial identifier NCT02443675, C4 OS-1

Summary

Observational Study of Pain Reduction in Late Stage Cancer Patients Receiving Low-Dose Chemotherapy

United States No locations recruiting
Other Countries No locations recruiting

Primary Outcomes

Measure
Pain Level Self Assessment
time frame: 5 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patient requests to be included in this study Exclusion Criteria: - Patient does not request to be included in this study

Additional Information

Official title Observational Study of Pain Reduction in Late-Stage Cancer Patients Who Are Receiving Low-Dose Chemotherapy
Description Observational Study of Pain Reduction in Late Stage Cancer Patients who are Receiving Low-Dose Chemotherapy (Metabolic Targeting)
Trial information was received from ClinicalTrials.gov and was last updated in May 2015.
Information provided to ClinicalTrials.gov by Cure Cancer Worldwide, LLC.